GlassScriptPhysician profile
Matthew James Dougherty
NPI 1255822599
$12,265.05
in general payments reported to CMS, 2019-2025
25 companies · $6,507 in 2025
The $6,507 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,211 · 2022: $258 · 2023: $832 · 2024: $3,457 · 2025: $6,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,446 · Travel and Lodging: $3,502 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,446.13 |
| Travel and Lodging | $3,501.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,848.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $4,766.18 | 2024-2025 | Restrata Wound Matrix |
| Orthofix Medical, INC. | $1,689.70 | 2024-2025 | Truelok, Tl-Hex Truelok Hexapod System, Physio-Stim |
| Liberty Surgical INC. | $1,210.84 | 2021 | |
| Arthrex, INC. | $750.29 | 2024 | |
| Stryker Corporation | $721.42 | 2022-2024 | Inbone |
| Coastal Medical Technologies LLC | $645.13 | 2023-2025 | |
| Linvatec Corporation | $641.03 | 2022-2025 | Biobrace 23mm, Fracture and Correction Colag 2, Colink Plating System |
| Ortho Solutions INC | $267.82 | 2023 | |
| Polynovo North America LLC | $223.62 | 2022-2023 | |
| Depuy Synthes Sales INC. | $176.89 | 2024-2025 | Na, Hammerlock, Motoband |
| Theramicro, INC. | $157.50 | 2025 | Microvisc, Allostat Gfx, Tekbrace Solo |
| Forma Medical | $146.66 | 2025 | Optimal Mtp |
| Biocomposites INC | $138.98 | 2025 | Stimulan |
| Mimedx Group, INC. | $109.87 | 2024-2025 | |
| Fusion Orthopedics USA, LLC | $107.28 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $95.27 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Flower Orthopedics Coporation | $92.69 | 2025 | |
| Restor3d, INC. | $61.72 | 2024 | |
| Treace Medical Concepts, INC. | $55.43 | 2024-2025 | |
| Smith+Nephew, INC. | $52.18 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl, Stravix |
| Lifenet Health | $45.09 | 2023 | |
| Averitas Pharma INC. | $33.36 | 2025 | Qutenza |
| Djo, LLC | $28.59 | 2024 | Cmf |
| Solventum Corporation | $27.82 | 2025 | Activ.A.C., Prevena |
| Bioventus LLC | $19.69 | 2023 | Theragenesis Bilayer Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.